2018
DOI: 10.1016/j.revmed.2018.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Rétinopathie sévère aux antipaludéens de synthèse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Antimalarials drugs (Hydroxy chloroquine and chloroquine) represent a first-line therapeutic option in the context of many systemic diseases in particular systemic lupus erythematosus (LES) with an excellent benefit /risk ratio, however they can be responsible of toxic retinopathy that can lead to blindness [1]. Recommendations for monitoring treatment at antimalarial drugs were the subject of updates in 2011 and 2016 by the American Academy of Ophthalmology (AAO) [2].…”
Section: Joj Ophthalmology Discussionmentioning
confidence: 99%
“…Antimalarials drugs (Hydroxy chloroquine and chloroquine) represent a first-line therapeutic option in the context of many systemic diseases in particular systemic lupus erythematosus (LES) with an excellent benefit /risk ratio, however they can be responsible of toxic retinopathy that can lead to blindness [1]. Recommendations for monitoring treatment at antimalarial drugs were the subject of updates in 2011 and 2016 by the American Academy of Ophthalmology (AAO) [2].…”
Section: Joj Ophthalmology Discussionmentioning
confidence: 99%